Histone 1, the guardian of genome stability
Researchers have explained for the first time that the suppression of histone 1 causes cell damage and genomic instability...
List view / Grid view
Researchers have explained for the first time that the suppression of histone 1 causes cell damage and genomic instability...
New research, has studied the immortalisation process using genome-engineered cells...
Scientists have described a novel immunotherapeutic strategy for the treatment of cancer based on the use of synthetic DNA...
Researcher have shown how a mRNA molecule known as Lethal-7 serves as a molecular control hub to direct the function of cytotoxic T lymphocytes...
A team of scientists have discovered what they say is a powerful pain reliever that acts on a previously unknown pain pathway...
At Charles River, we are passionate about fostering innovation as our commitment to ensure clients are provided with the most efficient path to market...
Researchers have developed a radioactive ‘tracer’ molecule to detect myeloid-derived suppressor cells’ accumulating in the lung in preparation for the arrival of breast cancer cells...
Scientists studying cellular enzyme complexes have unexpectedly found that inhibiting EZH2/1 suppressed viral infection in the herpes simplex virus infection...
A collaborative team of scientists have developed a novel synthetic vaccine with a method grown in plants that uses virus-like particles...
Researchers have shown that catching and treating breast cancer before it spreads is now a realistic goal...
Scientists have synthesised a complex sugar structure that specifically binds to the tumour protein Galectin-1...
A leading gene and cell therapy group has announced a collaboration focusing on gene and cell therapy manufacturing..
A research team have studied how alterations in a tumour depend on each other and how these dependencies determine cancer evolution...
Scientists have described a new type of test that can detect genetic mutations in minute amounts of DNA...
The U.S. Food and Drug Administration has granted an orphan-drug designation to cobitolimod for the treatment of ulcerative colitis in pediatric patients...